​

Creative Medical Technology Stock (NASDAQ:CELZ)

RevenueOwnershipFinancialsChart

Previous Close

$1.97

52W Range

$1.50 - $6.25

50D Avg

$1.97

200D Avg

$2.69

Market Cap

$5.01M

Avg Vol (3M)

$80.14K

Beta

2.15

Div Yield

-

CELZ Company Profile

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

4

IPO Date

Nov 06, 2015

Website

CELZ Performance

CELZ Financial Summary

Dec 24Dec 23Dec 22
Revenue$11.00K$9.00K$88.60K
Operating Income$-5.63M$-5.62M$-10.24M
Net Income$-5.49M$-5.29M$-10.04M
EBITDA$-5.63M$-5.53M$-10.15M
Basic EPS$-3.71$-3.76$-9.19
Diluted EPS$-3.71$-3.76$-9.19

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison

TickerCompany
ALZNAlzamend Neuro, Inc.
HCWBHCW Biologics Inc.
ADXNAddex Therapeutics Ltd
ACXPAcurx Pharmaceuticals, Inc.
ADILAdial Pharmaceuticals, Inc.
KPRXKiora Pharmaceuticals, Inc.
PHIOPhio Pharmaceuticals Corp.
APREAprea Therapeutics, Inc.
BCDABioCardia, Inc.
CDIOCardio Diagnostics Holdings, Inc.